The prevalence of increased adiposity among employees in the American workplace has resulted in significant economic costs to organizations. Unfortunately, relatively little research has examined the effects of excess adiposity on employees themselves. As a step toward remedying this, the current study examined a previously unknown link between adiposity and incivility, and how this might impact employee burnout and withdrawal. A student sample was used to initially establish a link between incivility and adiposity, and an applied sample of employees from across the United States was used to more fully test the relationships among incivility, adiposity, burnout, and withdrawal. Finally, the moderating effects of sex and race on these relationships were examined. Preliminary data from 341 student employees revealed that being overly adipose was related to greater reports of workplace incivility, with the effect strongest for those classified as obese. An interaction between sex and adiposity was also found, as well as a three-way interaction among sex, race, and adiposity. These relationships were replicated using a nationwide sample of 528 full-time employees. An interaction between race and adiposity was also found in this second sample. Finally, a model was tested in which incivility was shown to partially mediate the positive relationship between adiposity and the outcome of withdrawal, with both sex and race acting as moderators. Theoretical and practical implications of the findings and future directions are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/a0029862 | DOI Listing |
BMJ Open
January 2025
School of Public Health, University of Alberta, Edmonton, Alberta, Canada
Objective: To identify effective policies and non-policy interventions preventing youth vaping behaviour initiation and assess their effectiveness by the level of intrusiveness and subpopulations.
Design: This systematic rapid review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Data Sources: Searches on MEDLINE and APA-PsycINFO for studies published between January 2019 and November 2023.
J Am Geriatr Soc
January 2025
Geriatric Research, Education and Clinical Center, James J. Peters VA Medical Center, Bronx, New York, USA.
Background: Existing risk scores assessing geriatric vulnerability in the emergency department (ED) have shown limited predictive power, especially in diverse populations. We investigated the relationship of a quick and easy-to-administer geriatric vulnerability scoring system with functional decline and mortality in older patients admitted to multiple hospitals through the ED in the United States (US) and Brazil (BR).
Method: Federated, international, multicenter observational study of hospitalized ED patients aged ≥ 65 from US and BR.
BMJ Open Respir Res
January 2025
Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia.
Background: Globally, adult Indigenous people, including Aboriginal Australians, have a high burden of chronic respiratory disorders, and bronchiectasis is no exception. However, literature detailing bronchiectasis disease characteristics among adult Indigenous people is sparse. This study assessed the clinical profile of bronchiectasis among adult Aboriginal Australians and compared against previously published international bronchiectasis registry reports.
View Article and Find Full Text PDFRen Fail
December 2025
Department of Nephrology, Beijing Rehabilitation Hospital, Affiliated to Capital Medical University, Beijing, China.
Objective: This cross-sectional study aimed to investigate the association between drinking patterns and prevalence of diabetic kidney disease (DKD) among adults in the United States.
Methods: Data were analyzed from the NHANES surveys conducted between 1999 and 2016, including 26,473 participants. Drinking patterns were categorized by frequency (weekly, monthly, or yearly) and quantity (light, moderate, or heavy, based on daily consumption).
Pharmacoepidemiol Drug Saf
February 2025
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Purpose: To characterize long-term effects of COVID-19 among older adults (aged ≥ 65 years).
Methods: This retrospective descriptive study utilized Medicare Fee-for-Service beneficiaries' claims to characterize post-COVID condition diagnosis code usage, long COVID (defined as post-COVID condition diagnoses made ≥ 28 days after an initial COVID-19 diagnosis) incidence, patient demographics, and concurrent diagnoses.
Results: During April 1, 2020 to May 21, 2022, 193 691 (0.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!